Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.1 EUR | -0.82% | -5.43% | 0.00% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
0.00% | 541M | - | ||
+75.69% | 12.57B | B- | ||
-23.76% | 7.36B | C+ | ||
+13.12% | 6.59B | C- | ||
+17.81% | 5.67B | D+ | ||
-18.35% | 4.73B | B | ||
+18.27% | 4.22B | - | ||
-23.25% | 3.93B | B- | ||
+42.33% | 2.3B | C- | ||
+3.47% | 2.06B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SIBN Stock
- 2K3 Stock
- Ratings SI-BONE, Inc.